FR2366835A1 - Element de forme destine a renfermer une substance chimique, son procede de preparation et emballage le contenant - Google Patents

Element de forme destine a renfermer une substance chimique, son procede de preparation et emballage le contenant

Info

Publication number
FR2366835A1
FR2366835A1 FR7729663A FR7729663A FR2366835A1 FR 2366835 A1 FR2366835 A1 FR 2366835A1 FR 7729663 A FR7729663 A FR 7729663A FR 7729663 A FR7729663 A FR 7729663A FR 2366835 A1 FR2366835 A1 FR 2366835A1
Authority
FR
France
Prior art keywords
water
carrier
packaging
container
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7729663A
Other languages
English (en)
French (fr)
Other versions
FR2366835B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB41483/76A external-priority patent/GB1548022A/en
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Publication of FR2366835A1 publication Critical patent/FR2366835A1/fr
Application granted granted Critical
Publication of FR2366835B1 publication Critical patent/FR2366835B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Container Filling Or Packaging Operations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7729663A 1976-10-06 1977-10-03 Element de forme destine a renfermer une substance chimique, son procede de preparation et emballage le contenant Granted FR2366835A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB41483/76A GB1548022A (en) 1976-10-06 1976-10-06 Pharmaceutial dosage forms
GB3039977 1977-07-20

Publications (2)

Publication Number Publication Date
FR2366835A1 true FR2366835A1 (fr) 1978-05-05
FR2366835B1 FR2366835B1 (enExample) 1980-10-24

Family

ID=26260429

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7729663A Granted FR2366835A1 (fr) 1976-10-06 1977-10-03 Element de forme destine a renfermer une substance chimique, son procede de preparation et emballage le contenant

Country Status (12)

Country Link
JP (1) JPS5344619A (enExample)
AU (1) AU513845B2 (enExample)
CH (1) CH633717A5 (enExample)
CY (1) CY1129A (enExample)
DE (1) DE2744493A1 (enExample)
FR (1) FR2366835A1 (enExample)
HK (1) HK58081A (enExample)
IE (1) IE45770B1 (enExample)
KE (1) KE3171A (enExample)
LU (1) LU78259A1 (enExample)
MY (1) MY8200187A (enExample)
NL (1) NL189898C (enExample)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455459A1 (fr) * 1979-05-02 1980-11-28 Sertog Procede d'obtention d'une matrice contenant un principe actif et le liberant progressivement
EP0266113A1 (en) * 1986-10-21 1988-05-04 American Home Products Corporation Spray dried acetaminophen
EP0268383A1 (en) * 1986-10-21 1988-05-25 American Home Products Corporation Spray dried acetaminophen
EP0267702A3 (en) * 1986-10-21 1989-06-14 American Home Products Corporation Spray dried acetaminophen
EP0265226A3 (en) * 1986-10-21 1989-07-19 American Home Products Corporation Spray dried acetaminophen
EP0352190A1 (fr) 1988-07-21 1990-01-24 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou nanoparticules ainsi que sa préparation
EP0438358A1 (fr) 1990-01-19 1991-07-24 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa préparation
EP0450141A1 (en) * 1989-08-14 1991-10-09 Janssen Pharmaceutica Inc. Carrier material for administration of drugs
WO1993012770A1 (en) * 1991-12-20 1993-07-08 Pfizer Inc. Porous shaped delivery devices and method of producing thereof
WO1994001090A1 (de) * 1992-07-03 1994-01-20 Alfatec-Pharma Gmbh Feste und flüssige lösungen von schwer wasserlöslichen arzneistoffen
WO1995023600A1 (en) * 1994-03-02 1995-09-08 Akzo Nobel N.V. Sublingual or buccal pharmaceutical composition
WO1996013251A1 (en) * 1994-10-28 1996-05-09 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
WO1996026714A1 (en) * 1995-03-02 1996-09-06 R.P. Scherer Limited Process for the preparation of a solid pharmaceutical dosage form
WO1997006786A1 (en) * 1995-08-18 1997-02-27 R.P. Scherer Limited Oral fast-dissolving compositions for dopamine agonists
WO1999009989A1 (en) * 1997-08-21 1999-03-04 R. P. Scherer Limited Pharmaceutical composition containing midazolam
WO1999017754A1 (en) * 1997-10-08 1999-04-15 Sepracor Inc. Dosage form for aerosol administration

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53696B1 (en) * 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
AT385200B (de) * 1986-07-22 1988-02-25 Kwizda Fa F Johann Verfahren zur herstellung von tabletten mit retardierter freisetzungscharakteristik von arzneistoffen
JPH02247447A (ja) * 1989-03-17 1990-10-03 Matsushita Refrig Co Ltd 空気調和機の制御装置
FR2647343B1 (fr) * 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
JPH0331644A (ja) * 1989-06-28 1991-02-12 Matsushita Refrig Co Ltd 空気調和機の制御装置
ATE172637T1 (de) 1991-12-24 1998-11-15 Yamanouchi Pharma Co Ltd Intrabukkal desintegrierende zubereitung und ihre herstellung
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US5738875A (en) * 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
CA2258159C (en) 1996-06-14 2006-03-21 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
GB9722682D0 (en) * 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP4173670B2 (ja) * 2002-03-08 2008-10-29 旭化成ファーマ株式会社 口腔内崩壊製剤
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
AU2004216559B2 (en) * 2003-02-28 2010-05-27 Alk-Abello A/S Dosage form having a saccharide matrix
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
AU2005299490C1 (en) 2004-10-21 2012-01-19 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20080031944A1 (en) * 2006-08-04 2008-02-07 Cima Labs Inc. Stabilization of lorazepam
KR101765357B1 (ko) 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
JP2012121850A (ja) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
JP2015172084A (ja) * 2015-07-06 2015-10-01 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
JP6572257B2 (ja) * 2017-05-16 2019-09-04 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
FR2179044A1 (enExample) * 1972-04-03 1973-11-16 Scherer Corp R P
FR2199973A1 (enExample) * 1972-09-20 1974-04-19 Boehringer Mannheim Gmbh
FR2335205A2 (fr) * 1975-12-16 1977-07-15 Boehringer Mannheim Gmbh Procede pour la fabrication de comprimes poreux

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166074A (en) * 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
GB836811A (en) * 1955-07-08 1960-06-09 Ciba Ltd Shaped medicament carriers and process for their manufacture
GB1083896A (en) * 1964-04-30 1967-09-20 Dunster Lab Ltd Vehicles for administering drugs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
FR2179044A1 (enExample) * 1972-04-03 1973-11-16 Scherer Corp R P
FR2199973A1 (enExample) * 1972-09-20 1974-04-19 Boehringer Mannheim Gmbh
FR2335205A2 (fr) * 1975-12-16 1977-07-15 Boehringer Mannheim Gmbh Procede pour la fabrication de comprimes poreux

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455459A1 (fr) * 1979-05-02 1980-11-28 Sertog Procede d'obtention d'une matrice contenant un principe actif et le liberant progressivement
EP0266113A1 (en) * 1986-10-21 1988-05-04 American Home Products Corporation Spray dried acetaminophen
EP0268383A1 (en) * 1986-10-21 1988-05-25 American Home Products Corporation Spray dried acetaminophen
EP0267702A3 (en) * 1986-10-21 1989-06-14 American Home Products Corporation Spray dried acetaminophen
EP0265226A3 (en) * 1986-10-21 1989-07-19 American Home Products Corporation Spray dried acetaminophen
EP0352190A1 (fr) 1988-07-21 1990-01-24 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou nanoparticules ainsi que sa préparation
EP0450141A1 (en) * 1989-08-14 1991-10-09 Janssen Pharmaceutica Inc. Carrier material for administration of drugs
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
EP0438358A1 (fr) 1990-01-19 1991-07-24 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa préparation
WO1993012770A1 (en) * 1991-12-20 1993-07-08 Pfizer Inc. Porous shaped delivery devices and method of producing thereof
WO1994001090A1 (de) * 1992-07-03 1994-01-20 Alfatec-Pharma Gmbh Feste und flüssige lösungen von schwer wasserlöslichen arzneistoffen
WO1995023600A1 (en) * 1994-03-02 1995-09-08 Akzo Nobel N.V. Sublingual or buccal pharmaceutical composition
US5763476A (en) * 1994-03-02 1998-06-09 Akzo Noble N.V. Sublingual or buccal pharmaceutical composition
WO1996013251A1 (en) * 1994-10-28 1996-05-09 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
US5827541A (en) * 1994-10-28 1998-10-27 R. P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
WO1996026714A1 (en) * 1995-03-02 1996-09-06 R.P. Scherer Limited Process for the preparation of a solid pharmaceutical dosage form
US6423342B1 (en) 1995-03-02 2002-07-23 R. P. Scherer Corporation Process for the preparation of a solid pharmaceutical dosage form
WO1997006786A1 (en) * 1995-08-18 1997-02-27 R.P. Scherer Limited Oral fast-dissolving compositions for dopamine agonists
US6316027B1 (en) 1995-08-18 2001-11-13 R. P. Scherer Technologies, Inc. Fast-dissolving dosage forms for dopamine agonists
WO1999009989A1 (en) * 1997-08-21 1999-03-04 R. P. Scherer Limited Pharmaceutical composition containing midazolam
WO1999017754A1 (en) * 1997-10-08 1999-04-15 Sepracor Inc. Dosage form for aerosol administration

Also Published As

Publication number Publication date
IE45770L (en) 1978-04-06
KE3171A (en) 1981-12-18
IE45770B1 (en) 1982-11-17
LU78259A1 (enExample) 1978-06-09
NL189898C (nl) 1993-09-01
NL189898B (nl) 1993-04-01
AU2882577A (en) 1979-03-22
AU513845B2 (en) 1981-01-08
FR2366835B1 (enExample) 1980-10-24
MY8200187A (en) 1982-12-31
CY1129A (en) 1982-02-19
JPS6250445B2 (enExample) 1987-10-24
DE2744493A1 (de) 1978-04-13
DE2744493C2 (enExample) 1991-07-18
JPS5344619A (en) 1978-04-21
HK58081A (en) 1981-12-04
NL7710876A (nl) 1978-04-10
CH633717A5 (en) 1982-12-31

Similar Documents

Publication Publication Date Title
IE45770L (en) Pharmaceutical dosage forms
ATE109351T1 (de) Therapeutisches erzeugnis zur behandlung von beschwerden während der oder nach den wechseljahren.
RO79155A (ro) Procedeu pentru obtinerea de medivamente sub forma de pulberi,drajeuri sau tableta
NL175417C (nl) Werkwijze ter bereiding van een preparaat dat een organisch materiaal en een stabilisator bevat, de onder toepassing daarvan verkregen gevormde preparaten, alsmede werkwijze ter bereiding van voor toepassing bij genoemde werkwijze geschikte 2,2,6,6-tetra-alkylpiperidinederivaten.
FR2352791A1 (fr) P. acylaminobenzamides, procede pour leur preparation et medicaments contenant ces benzamides
FR2295747A1 (fr) Nouveaux azolyl-(1)-methanes et leurs sels, leur procede de preparation et medicaments les contenant
NL189128C (nl) Werkwijze voor de bereiding van 1,2,4-triazoolverbindingen, werkwijze voor de bereiding van preparaten voor de bestrijding van fungi die deze verbindingen bevatten, alsmede werkwijze voor het bestrijden van planteziekten.
NL178875B (nl) Werkwijze voor het bereiden van een 5-methylisoflavon en werkwijze voor het bereiden van een voederpreparaat of therapeutisch preparaat, dat een dergelijke verbinding bevat en gevormde voorwerpen vervaardigd onder toepassing van deze werkwijze.
ATE29662T1 (de) Verfahren zum schliessen des koerper- und kapselteils von hartgelatinekapseln und vorrichtung dafuer.
ATE72514T1 (de) Kapseln sowie verfahren und vorrichtung zur herstellung solcher kapseln.
NL164472B (nl) Werkwijze ter bereiding van een voor orale toediening geschikt farmaceutisch preparaat dat geschikt is voor de behandeling van oesofagitis, alsmede onder toe- passing daarvan verkregen voorwerp.
FR2331343A1 (fr) Nouvelle spiro(1,3-dioxolane-4,3')quinuclidine, son procede de preparation et medicament la contenant
BE857289A (fr) 2-benzyl-pyrrolidines, procede pour leur preparation et medicaments contenant ces composes
FR2289192A1 (fr) Pyrazolo(1,5-a)pyridines et medicament contenant ces substances
BE762768A (fr) Procede de fabrication d'emballage ouverts ou fermes en matieres spongieuses, de preference en mousse de
FR2339397A1 (fr) Nouveaux ethers d'oximes, procede de preparation de ceux-ci et medicaments les contenant
NL7514618A (nl) Werkwijze voor de bereiding van farmacologisch werkzame verbindingen, werkwijze voor de berei- ding van een geneesmiddel ten gebruike voor de behandeling of voorkoming van hyperlipoproteine- mie, alsmede een dergelijk geneesmiddel.
FR2342069A1 (fr) Nouvelles benzodiazepinones, leur procede de preparation et medicament les contenant
HU169442B (en) Herbicides containing arometins of 4-amin-5-h-1,2,4-triasine-5-ans and process for production of the active substance
NL7508601A (nl) Werkwijze voor de bereiding van een veterinair ge- neesmiddel met anticoccide- en antimicrobische wer- king, geneesmiddel met een dergelijke werking en werkwijze voor de bereiding van de werkzame verbin- dingen.
NL155827B (nl) Werkwijze voor de bereiding van antibacterieel werkzame benzylpyrimidinen, alsmede voor de bereiding van antibacterieel werkzame preparaten, die deze verbindingen bevatten, en de gevormde preparaten.
BE821142A (fr) Procede d'emballage sous pellicule de matiere plastique
NL166010C (nl) Werkwijze voor de bereiding van een geneesmiddel met anti-arteriosclerotische werkzaamheid, gevormd genees- middel en werkwijze voor de bereiding van anti- -arteriosclerotisch werkzame abietamidederivaten.
NL166188C (nl) Werkwijze voor het bereiden van een op de stof- wisseling werkend geneesmiddel, dat een purine-3',5' -cyclofosfaatverbinding bevat, gevormd geneesmiddel verkregen onder toepassing van deze werkwijze en werkwijze voor het bereiden van een purine-3',5'- -cyclofosfaatverbinding, geschikt voor gebruik bij genoemde werkwijze voor de bereiding van een geneesmiddel.
CA962588A (en) Method, apparatus, and fungicides for the treatment of trees subject to dutch elm disease and other fungus diseases